The second wave of corona infection is proving very dangerous and more than 4 lakh record cases are coming out every day. A relief news has come on Saturday amid increasing cases of infection. Drug regulator DGCI has approved the emergency use of a drug for the treatment of corona. This drug has been developed by DRDO. Drug2-deoxy-D-glucose (2-DG) has been prepared by DRDO in collaboration with leading pharmaceutical company Dr. Reddy’s Laboratories. This drug has been found effective in controlling the growth of the corona virus. According to the DGCI, effective control of the growth of the virus with the use of this drug led to a rapid recovery in the health of hospitalized corona patients. In addition, it reduces the need for medical oxygen.
The drug was developed by DRDO last year and between April 2020 to March 2021, three phase clinical trials have taken place. This drug can be produced on a large scale as soon as possible, that is, its shortage will not come in the way of treatment of corona infected. It comes in the form of a powder and can be dissolved in water and given to patients.
Virafin gets approval for treatment of corona, report claims to be negative in 7 days during test
Three clinical trials between April 2020 and March 2021
- The trial of the first phase of the drug was completed in April-May 2020. In this, experiments were done on the drug in the lab.
- DCGI approved the second phase of clinical trial between May 2020 and October 2020. In the second phase clinical trial, 110 patients admitted to 11 hospitals of the country were included. Patients involved in the trial recovered 2.5 days earlier than other patients.
States got approval to develop their own app like CoWin, Maharashtra CM Uddhav Thackeray requested Modi government
- In November 2020, DRDO applied for the clinical trial of Phase III of the drug. For this, the trial was approved from December 2020 to March 2021. In this phase, the drug was tested on 220 patients in 27 hospitals located in Delhi, Uttar Pradesh, West Bengal, Gujarat, Rajasthan, Maharashtra, Andhra Pradesh, Telangana, Karnataka and Tamil Nadu. This test found that 42% of the patients using 2-DG did not need medical oxygen from the third day, whereas only 31 of the patients who were not given this medicine, ended their dependence on medical oxygen from the third day. Hui. The drug also showed similar effects on the elderly over 65 years.
Get Business News in Hindi, latest India News in Hindi, and other breaking news on share market, investment scheme and much more on Business Khabar. Like us on Facebook, Follow us on Twitter for latest financial news and share market updates.
.